Fertility & IVF Treatment Data
Buy and sell fertility & ivf treatment data data. Cycle protocols, embryo grading, transfer outcomes — reproductive AI needs real IVF treatment-to-pregnancy data.
No listings currently in the marketplace for Fertility & IVF Treatment Data.
Find Me This Data →Overview
What Is Fertility & IVF Treatment Data?
Fertility and IVF treatment data encompasses clinical records from assisted reproductive technology (ART) procedures, including cycle protocols, embryo grading systems, transfer outcomes, and live-birth results. This data is essential for reproductive AI development, enabling machine learning models to improve embryo selection, predict cycle success, and optimize stimulation protocols. The data includes patient demographics, treatment timelines, procedural details from fresh and frozen cycles, and donor management records—all collected across fertility clinics, hospitals, and research institutes globally.
Market Data
USD 37.1 billion
Global Fertility Treatment Market Size (2026)
Source: Mordor Intelligence
USD 180.6 million
IVF Software Market Valuation (2023)
Source: DataIntelo
USD 52.33 billion
Fertility Treatment Market Projected Size (2031)
Source: Mordor Intelligence
46.58%
IVF Revenue Share (2025)
Source: Mordor Intelligence
USD 12,000–30,000
U.S. IVF Cost Per Cycle
Source: Mordor Intelligence
Who Uses This Data
What AI models do with it.do with it.
Reproductive AI & Embryo Assessment
AI developers train models on cycle protocols and embryo grading data to improve automated embryo selection, predict implantation success, and optimize morphology scoring algorithms.
Clinical Decision Support
Fertility clinics and hospitals use historical cycle outcomes, transfer data, and pregnancy results to benchmark their protocols, refine patient selection criteria, and improve live-birth rates.
Research & Protocol Development
Research institutes analyze large-scale treatment datasets to identify optimal stimulation protocols, compare fresh versus frozen cycle outcomes, and advance understanding of male and female infertility mechanisms.
Medical Device & Pharmaceutical Development
Manufacturers of culture media, monitoring devices, and fertility drugs use treatment outcome data to validate product efficacy, design clinical trials, and support regulatory submissions.
What Can You Earn?
What it's worth.worth.
Cycle Protocol Datasets
Varies
Anonymized stimulation protocols, medication logs, and trigger timing commands premium rates from AI labs developing prediction models.
Embryo Grading & Selection Data
Varies
Morphology grades, time-lapse imaging annotations, and blastocyst quality metrics support high-value AI training in embryo assessment.
Transfer Outcome Records
Varies
Pregnancy outcomes, implantation success, miscarriage rates, and live-birth data tied to treatment variables are highly sought by researchers and clinical platforms.
Donor & Donor Semen Management Data
Varies
De-identified donor profiles, semen analysis results, and cycle success rates for donor-assisted procedures command interest from clinic networks and registry operators.
What Buyers Expect
What makes it valuable.valuable.
Clinical Accuracy & Traceability
Buyers require validated embryo grading per standard classification systems, accurate cycle dates, and documented treatment decisions tied to measurable outcomes; data must be verifiable against clinic records.
Regulatory & Privacy Compliance
All datasets must be de-identified to HIPAA/GDPR standards, with consent documentation proving patient authorization for research use; institutional review board (IRB) approval or equivalent ethical clearance required.
Longitudinal Follow-Up
Buyers prioritize datasets with complete pregnancy tracking, live-birth confirmation, and long-term outcomes (e.g., miscarriage rates, multiple pregnancies); isolated snapshots of single procedures have lower value.
Structured & Complete Records
Data must include standardized fields: patient age, infertility diagnosis, medication protocols, egg/sperm quality metrics, fertilization rates, embryo morphology, transfer details, and clinical pregnancy confirmation.
Scale & Diversity
Larger cohorts (hundreds to thousands of cycles) across diverse patient populations, treatment types (fresh, frozen, donor), and geographic regions increase utility for AI training and statistical analysis.
Companies Active Here
Who's buying.buying.
License cycle and embryo grading datasets to train machine learning models predicting implantation potential, morphology evolution, and time-to-blastocyst development.
Command 67.62% of 2025 market revenue and procure anonymized benchmarking data to compare their cycle outcomes, refine protocols, and improve clinical performance against peer networks.
Manage over 40% of IVF cycles and acquire aggregated outcome datasets to standardize protocols across locations, automate quality assurance, and support expansion into male infertility and tele-fertility.
Purchase large clinical datasets to publish studies on protocol efficacy, conduct comparative analysis of fresh versus frozen cycles, and investigate emerging treatments like stem-cell-matured oocytes.
FAQ
Common questions.questions.
What types of IVF data are most valuable?
Embryo grading and morphology data, complete cycle protocols with medication logs, and longitudinal outcome records (pregnancy confirmation through live birth) command the highest prices. AI developers especially value time-stamped embryo assessments tied to implantation success.
How is patient privacy protected when selling this data?
All datasets must be de-identified according to HIPAA or GDPR standards, with direct identifiers removed. Buyers require documented patient consent for research use and institutional review board (IRB) approval; reputable data brokers verify these safeguards before purchase.
Which regions have the highest demand for IVF data?
North America holds 38.11% of global fertility treatment revenue and drives demand for clinical datasets. Asia-Pacific is expanding rapidly at 8.12% CAGR through 2031, creating growing opportunities in China, India, and Southeast Asia as clinic networks consolidate and adopt AI tools.
What is the difference between fresh and frozen cycle data?
Fresh non-donor cycles captured 54.41% of the market in 2025, but frozen/thawed non-donor cycles are expanding at 9.28% CAGR. Frozen cycle data is increasingly valuable because it represents a growing segment and offers distinct insights into embryo viability after cryopreservation and thaw.
Sell yourfertility & ivf treatmentdata.
If your company generates fertility & ivf treatment data, AI companies are actively looking for it. We handle pricing, compliance, and buyer matching.
Request Valuation